|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2009-7-13
|
|
pubmed:abstractText |
Pancreatic cancer is one of the most aggressive gastrointestinal cancer with less than 10% long-term survivors. The apoptotic pathway deregulation is a postulated mechanism of carcinogenesis of this tumor. The present study investigated the prognostic role of MUC2 and MUC5 apomucin expression in a series of surgically resected pancreatic cancer patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1555-8576
|
|
pubmed:author |
pubmed-author:AntinoriArmandoA,
pubmed-author:BaldiAlfonsoA,
pubmed-author:BorzomatiDomenicoD,
pubmed-author:CaragliaMicheleM,
pubmed-author:CastriFedericaF,
pubmed-author:CoppolaRobertoR,
pubmed-author:MagistrelliPaoloP,
pubmed-author:PantanoFrancescoF,
pubmed-author:SantiniDanieleD,
pubmed-author:ToniniGiuseppeG,
pubmed-author:VecchioFabio MariaFM,
pubmed-author:VincenziBrunoB
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
996-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19587537-Adenocarcinoma,
pubmed-meshheading:19587537-Adult,
pubmed-meshheading:19587537-Aged,
pubmed-meshheading:19587537-Aged, 80 and over,
pubmed-meshheading:19587537-Cohort Studies,
pubmed-meshheading:19587537-Female,
pubmed-meshheading:19587537-Humans,
pubmed-meshheading:19587537-Immunohistochemistry,
pubmed-meshheading:19587537-Kaplan-Meier Estimate,
pubmed-meshheading:19587537-Male,
pubmed-meshheading:19587537-Middle Aged,
pubmed-meshheading:19587537-Mucin-2,
pubmed-meshheading:19587537-Mucin-5B,
pubmed-meshheading:19587537-Pancreatic Neoplasms,
pubmed-meshheading:19587537-Prognosis,
pubmed-meshheading:19587537-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.
|
|
pubmed:affiliation |
Medical Oncology, University Campus Bio-Medico of Rome, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article
|
